Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 30;26(7):3205.
doi: 10.3390/ijms26073205.

Role of Endothelin-1 and Nitric Oxide in Acute Ischemic Stroke Leptomeningeal Collateral Activation

Affiliations

Role of Endothelin-1 and Nitric Oxide in Acute Ischemic Stroke Leptomeningeal Collateral Activation

Marta Iacobucci et al. Int J Mol Sci. .

Abstract

Good leptomeningeal collaterals (LMCs) after large vessel occlusion (LVO) extend the time window for endovascular therapy. The mechanisms regulating LMC activation are not fully understood. The aim of this study was to investigate the potential role of two vasoactive molecules endothelin-1 (ET-1)-a vasoconstrictor agent-and nitric oxide (NO)-a vasodilator agent-in the regulation of post-stroke LMCs. Ischemic stroke patients within 6 h of LVO were included. Collateral status was assessed using the Menon scoring system based on computed tomography angiography scans. Patients were accordingly divided into three groups: poor, intermediate, and good LMCs. Recanalization was evaluated using the modified thrombolysis in cerebral infarction (mTICI) score. Serum levels of ET-1 and NO were measured at three time points: T0 (<6 h), T1 (24 h), and T2 (48 h). A total of 105 patients were enrolled (mean age 76 ± 12.8 years): 44 with good (46.2%), 36 with intermediate (37.8%), and 22 with poor LMCs (23.1%). NO values decreased, whereas ET-1 values increased from T0 to T1 in all groups of patients. No significant association was found between serum ET-1 levels and collateral status. Higher ET-1 levels at T1 correlated with poor outcome regardless of the LMC status or the degree of recanalization (p = 0.030). A significant linear positive correlation was revealed at T0 between high levels of ET-1 and the neutrophil count (Spearman's rho = 0.236, p = 0.035). Subgroup analysis showed a significant inverse correlation at T1 between NO and the collateral score (Spearman's rho = -0.251, p = 0.021). Although we observed no significant association between LMC score and serum ET-1 concentrations, at 24 h higher ET-1 serum levels were predictive of poor outcome and higher NO levels were correlated with poor collateral status. These findings may indicate an inadequate microvascular reperfusion, possibly due to ET-1-mediated vasoconstriction, neutrophil activation, and NO-mediated oxidative stress, suggesting their potential role in the no-reflow phenomenon.

Keywords: ET-1; NO; acute ischemic stroke; leptomeningeal collaterals; reperfusion.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Temporal course of peripheral biomarkers (ET-1 and NO) in the three collateral groups.
Figure 2
Figure 2
Differences in biomarker values from peripheral and intracranial blood by collateral status over time (from T0 to T2). (A) ET-1 values from peripheral blood samples, (B) ET-1 values from intracranial blood samples (pre- and post-occlusion), (C) NO values from peripheral blood samples, and (D) NO from intracranial blood samples (pre- and post-occlusion). No statistically significant differences were observed in ET-1 or NO concentrations between the three groups at any of the analyzed time points. Mean biomarker concentrations for each group and time point are reported in Supplementary Tables S4 and S5.
Figure 3
Figure 3
Significant correlation between the peripheral NO values (μM) and the collateral score at T1.
Figure 4
Figure 4
Significant correlation between the peripheral ET-1 values (pg/mL) and the neutrophil count at T0.

Similar articles

References

    1. Vagal A., Aviv R., Sucharew H., Reddy M., Hou Q., Michel P., Jovin T., Tomsick T., Wintermark M., Khatri P. Collateral Clock Is More Important Than Time Clock for Tissue Fate. Stroke. 2018;49:2102–2107. doi: 10.1161/STROKEAHA.118.021484. - DOI - PMC - PubMed
    1. De Michele M., Lorenzano S., Bertuccini L., Iosi F., Toni D. “Time lost is clot resolution lost”: The neglected perspective of the therapeutic time window for ischemic stroke. Front. Neurol. 2023;14:1177609. doi: 10.3389/fneur.2023.1177609. - DOI - PMC - PubMed
    1. Nogueira R.G., Jadhav A.P., Haussen D.C., Bonafe A., Budzik R.F., Bhuva P., Yavagal D.R., Ribo M., Cognard C., Hanel R.A., et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct. N. Engl. J. Med. 2018;378:11–21. doi: 10.1056/NEJMoa1706442. - DOI - PubMed
    1. Albers G.W., Marks M.P., Kemp S., Christensen S., Tsai J.P., Ortega-Gutierrez S., McTaggart R.A., Torbey M.T., Kim-Tenser M., Leslie-Mazwi T., et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N. Engl. J. Med. 2018;378:708–718. doi: 10.1056/NEJMoa1713973. - DOI - PMC - PubMed
    1. Rocha M., Jovin T.G. Fast versus slow progressors of infarct growth in large vessel occlusion stroke: Clinical and research implications. Stroke. 2017;48:2621–2627. doi: 10.1161/STROKEAHA.117.017673. - DOI - PubMed

LinkOut - more resources